Search
for

    Glossary Golimumab

    medication that inhibits TNF-alpha to treat autoimmune diseases

    Golimumab is a medication used to treat autoimmune conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in inflammation and immune system responses. This helps reduce symptoms and prevent joint damage in affected individuals.

    Sort by

    Research 30 of 48

    1. First two cases of alopecia areata during golimumab therapy Joint bone spine · 2015 · 1 citations
    2. Interventions for nail psoriasis Cochrane library · 2013 · 65 citations
    3. Repigmentation of hair following adalimumab therapy Dermatology online journal · 2015 · 17 citations
    4. An adult case of suspected A20 haploinsufficiency mimicking polyarteritis nodosa Lara D. Veeken · 2022 · 5 citations
    5. Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition Journal of Dermatological Treatment · 2026 · 1 citations
    6. P07 Pityriasis amiantacea: a unique presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy Rheumatology advances in practice · 2023 · 1 citations
    7. CASE REPORT: BIOLOGICAL THERAPY ASSOCIATION, CASE REPORT OF A PATIENT WITH ANKYLOSING SPONDYLITIS AND ALOPECIA AREATA 2024
    8. Adverse Effects and Drug Interactions of Biologic Agents Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2010
    9. From the Cochrane Library: Interventions for Nail Psoriasis Dermatology · 2025
    10. Medication-Induced Repigmentation of Gray Hair: A Systematic Review Skin appendage disorders · 2019 · 28 citations
    11. Guía clínica chilena para el estudio y tratamiento de hidradenitis supurativa. Resumen ejecutivo Revista médica de Chile · 2021 · 10 citations
    12. Ottawa, Ontario, Canada, February 13–16, 2013 The Journal of Rheumatology · 2013 · 4 citations
    13. Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy Dermatology and Therapy · 2026
    14. Psoriasis and Alopecia: Unveiling the Links Dermatology Practical & Conceptual · 2025
    15. Treating Psoriasis: What Is New About Fumaric Acid Esters? European Medical Journal · 2018
    16. Poster Abstracts Fundamental & Clinical Pharmacology · 2017
    17. Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych 2024
    18. Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata Clinical Journal of Gastroenterology · 2020 · 2 citations
    19. Drug-induced alopecia areata: A systematic review Journal of the American Academy of Dermatology · 2023 · 3 citations
    20. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature Journal of International Medical Research · 2024 · 2 citations
    21. Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors InTech eBooks · 2018 · 2 citations
    22. Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review PloS one · 2024
    23. Psoriatic Alopecia in a Patient With Crohn Disease: An Uncommon Manifestation of Tumor Necrosis Factor α Inhibitors Cutis · 2021
    24. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Journal of the American Academy of Dermatology · 2019 · 256 citations
    25. Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases Frontiers in medicine · 2022 · 59 citations
    26. Methotrexate for maintenance of remission in ulcerative colitis Cochrane library · 2015 · 51 citations
    27. The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience Frontiers in Pediatrics · 2022 · 35 citations
    28. Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis BMC musculoskeletal disorders · 2016 · 23 citations
    29. Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising Arthritis research & therapy · 2017 · 20 citations
    30. The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19 Frontiers in Pharmacology · 2022 · 15 citations